Table 3.
Variables | OR | 95% CI | P value |
---|---|---|---|
Age (years) | 1.025 | 1.002–1.049 | 0.037 |
Gender, n (%) | 1.157 | 0.838–1.597 | 0.375 |
Vital signs | |||
T(◦C) | 1.140 | 0.938–1.387 | 0.189 |
RR (bpm) | 1.017 | 0.982–1.054 | 0.350 |
HR (bpm) | 1.002 | 0.994–1.010 | 0.636 |
MAP (mmHg) | 0.976 | 0.968–0.985 | < 0.001 |
Laboratory test | |||
WBC (× 109/L) | 1.037 | 1.014–1.060 | 0.001 |
Monocyte (× 109/L) | 1.108 | 0.793–1.550 | 0.547 |
NEUT (%) | 1.035 | 1.021–1.049 | < 0.001 |
Lymphocyte (× 109/L) | 0.613 | 0.461–0.813 | 0.001 |
PLT (× 109/L) | 0.992 | 0.990–0.994 | < 0.001 |
PCT (ng/ml) | 1.030 | 1.021–1.040 | < 0.001 |
PTA (%) | 0.968 | 0.960–0.976 | < 0.001 |
TT (S) | 1.008 | 0.999–1.018 | 0.095 |
INR | 10.316 | 5.027–21.169 | < 0.001 |
FDP (mg/L) | 1.012 | 1.006–1.019 | < 0.001 |
D-D (mg/L) | 1.039 | 1.018–1.060 | 0.038 |
FIB (g/L) | 0.984 | 0.906–1.070 | 0.707 |
APTT (S) | 1.039 | 1.022–1.057 | < 0.001 |
PT (S) | 1.045 | 1.019–1.071 | 0.001 |
AGR | 0.301 | 0.189–0.477 | < 0.001 |
Globulin (g/L) | 1.007 | 0.982–1.032 | 0.604 |
ALB (g/L) | 0.981 | 0.965–0.997 | 0.019 |
Bilirubin (mg/dl) | 1.001 | 0.999–1.004 | 0.232 |
Urinary glucose (mmol/L) | 0.994 | 0.981–1.006 | 0.314 |
UA (umol/L) | 1.004 | 1.002–1.005 | < 0.001 |
Cystatin C (mg/L) | 2.787 | 2.139–3.631 | < 0.001 |
BUN (mmol/L) | 1.129 | 1.095–1.165 | < 0.001 |
Cr (umol/L) | 1.018 | 1.013–1.022 | < 0.001 |
TC (mmol/L) | 0.565 | 0.863–1.079 | 0.529 |
T body temperature, HR heart rate, RR respiratory rate, MAP mean arterial pressure, WBC white blood cell, NEUT% neutrophil percentage, PLT platelet, PCT serum procalcitonin, PTA prothrombin time activity, TT thrombin time, INR international normalized ratio, FDP fibrinogen degradation products, D-D D-Dimer, FIB fibrinogen, APTT activated partial thromboplastin time, PT prothrombin time, AGR albumin globulin ratio, BUN blood urea nitrogen, Cr creatinine, TC total cholesterol